View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 13, 2020updated 02 Nov 2021 8:51am

Abbott and 3M the most recalled companies fighting the COVID-19 crisis: Poll

While a number of medical device companies have geared up to fight against the COVID-19 crisis, Verdict tried to find which companies got more popular in helping to solve the crisis, through a poll.

While a number of medical device companies have geared up to fight against the COVID-19 crisis, Verdict tried to find which companies got more popular in helping to solve the crisis, through a poll.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

Analysis of the poll results showed that Abbot and 3M are the first companies that came to mind for the majority of the respondents. Abbott and 3M were chosen by 27% and 25% of the respondents, respectively.

The poll included six more companies to choose from, namely Roche Diagnostics, ThermoFisher, Quest Diagnostics, Becton Dickinson and Co, BioMerieux, and Bio-Rad Laboratories.

A lesser 13% chose Roche Diagnostics as the most recalled company helping to fight the crisis, followed by ThermoFisher at 6%. The remaining four companies accounted for less than 5% of the responses, each.Most recalled medicaldevice companies poll

It’s interesting to see that a significant 18% couldn’t recollect any of the eight companies being at the forefront of the fight against COVID-19.

The analysis was based on 391 responses received between 26 March and 08 April.

Abbott and 3M’s efforts during the COVID-19 crisis

Abbott launched a rapid point-of-care test named ID NOW, for the detection of coronavirus, in March 2020. The company is producing 50,000 tests a day currently and plans to increase the production capacity of ID NOW tests to two million a month by June. The ID NOW rapid test detects a coronavirus-positive result in five minutes, while a negative result takes 13 minutes to be confirmed.

Abbott also offers coronavirus tests for its molecular laboratory instrument named m2000 RealTime, which can perform 470 tests a day and takes 6.5 hours to deliver results. The company is currently producing one million molecular tests a week for the m2000 system, which are being shipped within the US as well as being exported to other countries.

3M, which produces respirators that are one of the critical devices during the COVID-19 outbreak, started importing respirators from its overseas manufacturing operations into the US. Although the Federal administrators requested to stop exporting respirators the company manufactures in the US to Canada and Latin America, the company took a humanitarian and strategic stand by continuing to export respirators.

3M currently produces 35 million N95 masks a month in the US alone, while ten million N95 masks will be exported to the US from 3M Chinese operations initially. The N95 imports from 3M operations will be increased to 166.5 million over the next three months starting this month to support healthcare workers, the company announced on 06 April.

3M has doubled its global N95 respirators production to 1.1 billion a year in 2020 and plans to gradually double it further to approximately two billion within 12 months.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network